With strong CYP2B6 inhibitors: Max 1 tablet twice daily (Medscape, 2025)
a separate, higher-dose formulation is approved for chronic weight management only in adults who meet specific BMI criteria
Based on VigiBase, the World Health Organizations (WHO) adverse drug reaction database, intestinal obstructions are reported over 4.5 times more frequently with incretin-based drugs than with other diabetes medications [10]
Summary: Saxenda may fail to suppress appetite or cause increased hunger due to insufficient dosing, incorrect injection technique, medication storage issues, dietary composition, psychological factors, underlying medical conditions, or inadequate sleep
When you first get started on medication, your provider will work with you to adjust your medication dose
Connection between weight loss and better sleep Obesity represents the primary modifiable risk factor for obstructive sleep apnea (OSA) 34